Martin Gomez

Martin Gomez is a partner in Goodwin’s Technology Companies group specializing in intellectual property matters. Martin focuses his practice on advising technology and life sciences companies of all sizes (including startups), and their investors, in corporate and especially intellectual property matters throughout the business life cycle, including new company formation, IP protection, fundraising, strategic transactions, and exits.

Martin is also a registered patent attorney. His practice includes intellectual property rights counseling, procurement, and enforcement, with significant experience in strategic patent portfolio development, transactional IP diligence, IP licensing, and patent and trade secret litigation. Martin also has special expertise with design patents, both in obtaining design patent protection for clients and in evaluating design patent portfolios in the transactional and litigation contexts.

Martin has a technical background in mechanical and biomedical engineering and has particular technical expertise in the areas of medical devices, laboratory testing / diagnostic equipment, and healthcare IT. He also regularly advises clients in other technology areas, including robotics, clean energy, consumer products, and computer-implemented / software-based technologies.
In addition to his practice before the U.S. Patent and Trademark Office, Martin also has experience litigating patent and trade secret disputes before the federal courts. He has researched and drafted substantive motions / briefs, prepared expert reports, and participated in depositions and hearings concerning invalidity and non-infringement.

Martin also maintains a robust pro bono practice. He assists local small businesses and entrepreneurs through Goodwin’s Neighborhood Business Initiative (NBI) and immigrant children through the Kids in Need of Defense (KIND) program. Martin was the recipient of the 2019 Robert B. Fraser Pro Bono Award, given annually by the firm to one associate and one partner that have made significant contributions to the firm’s pro bono efforts.

Martin was the recipient of Boston University College of Engineering’s award for best senior project for developing a laboratory testing device used by biomedical researchers assessing the effects of spinal loading on patients.

While attending law school, Martin served as Editor-in-Chief of IDEA: The Intellectual Property Law Review, an academic journal publishing articles related to patent, copyright, trademark, trade secret, unfair competition, and other law and technology issues from around the world.

Upon graduation from law school, Martin received the ALI/ABA Scholarship & Leadership Award, awarded by the faculty to the graduating law student who best represents scholarship and leadership.

• Co-Author, “Top 5 Compliance Issues for Medtech Firms Transitioning To Data-Enabled Solutions,” MedCity News, January 27, 2023
• Co-Author, “Top 5 FDA Considerations for Medtech-Enabled Data Platforms,” MedCity News, January 24, 2023
• Co-Author, “Top 5 IP Considerations for Medtech Companies Transitioning To Data-enabled Product Solutions,” MedCity News, January 20, 2023

Martin regularly prepares presentations for industry groups and attorneys on intellectual property topics. Recent examples include:

• “Intellectual Property for Food Labeling,” BizGrow, 2017
• A presentation to Boston’s Commonwealth Kitchen on IP topics related to the food industry, with a particular focus on trademarks, Summer 2016
• A presentation to the New England Corporate Counsel Association (NECCA) on key IP-related contract provisions, Fall 2014
• A presentation to attorneys regarding new post-grant patent challenge proceedings implemented by the America Invents Act (e.g., IPRs, PGRs, CBMs), Fall 2013

Martin is also a published author on the topic of recent statutory changes to U.S. patent law enacted by the America Invents Act.

• Author, “Manufacturing Please Come Home: How AIA’s Prior User Right Could Be the American Economy’s Savior,” UC Davis Business Law Journal, Fall 2013